PATENT CLAIM ANALYSIS

Application Number: 15877996
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["536", "024200"]

Abstract:
Viral infection is a persistent cause of human disease. Guided nuclease systems of the invention target the genomes of viral infections, rendering the viruses incapacitated. The invention further provides delivery methods and compositions for antiviral therapeutics. Methods and compositions are provided for targeted delivery of antiviral therapeutics into cells of interest using, for example, viral vectors such as adenovirus, AAV, and replication incompetent HSV. These and other delivery systems can be used as vehicles to deliver DNA vectors encoding a nuclease or a cell-killing gene. These delivery methods can also be used to deliver naked DNA or RNA, protein products, plasmids containing a promoter that is active only in a latent viral state which drives a cell-killing gene, or other therapeutic agents.

Claim (Index 1):
A composition comprising guide RNAs for use in the treatment of latent viruses within a cell.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.67901
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14725943', '14790748', '15167204', '15441089', '14971356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5457118804354432
- 35 USC 102 Novelty (BERT): 0.5660124624448283
- Combined Prediction Score: 0.5477419386363817
- Mean Citation Score: 401.922522
- Max Citation Score: 492.6762
- Similarity Product: 332.7281426466465

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test